Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Express Scripts

Generated: November 20, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,403,858

« Back to Dashboard

Summary for Patent: 5,403,858

Title: New compositions containing taxane derivatives
Abstract:Compositions containing taxane derivatives, consist of a solution of such derivative in a surfactant consisting of polysorbate, polyethelene glycol or hydrogenated castor oil. These compositions can be used to prepare perfusion solutions essentially free of ethanol.
Inventor(s): Bastard; Jean-Pierre (Lesigny, FR), Dupechez; Thierry (Villemoisson sur Orge, FR), Fabre; Jean-Louis (Paris, FR)
Assignee: Rhone-Poulenc Rorer, S.A. (Antony, FR)
Application Number:07/930,392
Patent Claim Types:
see list of patent claims
Composition; Compound; Process; Formulation;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,403,858

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France91 08527Jul 8, 1991
PCT Information
PCT FiledJuly 03, 1992PCT Application Number:PCT/FR92/00624
PCT Publication Date:January 21, 1993PCT Publication Number: WO93/00928

International Patent Family for Patent: 5,403,858

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria147992► Subscribe
Austria161193► Subscribe
Australia2278792► Subscribe
Australia666859► Subscribe
Canada2102777► Subscribe
Canada2102778► Subscribe
Czech Republic280965► Subscribe
Czech Republic9400032► Subscribe
Germany69217056► Subscribe
Germany69223624► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Argus Health
Farmers Insurance
Express Scripts
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus